Short Interest in Concord Medical Services Holdings Limited (NYSE:CCM) Expands By 55.7%

Concord Medical Services Holdings Limited (NYSE:CCM) was the target of a large growth in short interest in July. As of July 31st, there was short interest totaling 4,641 shares, a growth of 55.7% from the July 15th total of 2,980 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 57,272 shares, the days-to-cover ratio is presently 0.1 days.

Concord Medical Services Stock Down 2.1%

Shares of Concord Medical Services stock opened at $4.66 on Tuesday. The company has a current ratio of 0.48, a quick ratio of 0.46 and a debt-to-equity ratio of 1.33. The company has a 50-day simple moving average of $4.62 and a two-hundred day simple moving average of $4.29. Concord Medical Services has a one year low of $3.18 and a one year high of $6.98.

Analysts Set New Price Targets

A number of equities analysts have commented on CCM shares. Wall Street Zen raised shares of Concord Medical Services to a “hold” rating in a research note on Saturday. Weiss Ratings reiterated a “sell (e+)” rating on shares of Concord Medical Services in a research note on Tuesday, May 26th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.